
The vaccine rollout in Australia, argues Markela Panegyres, has been held back by the lack of publicly-owned vaccine infrastructure and the government's own vaccine nationalism.
The vaccine rollout in Australia, argues Markela Panegyres, has been held back by the lack of publicly-owned vaccine infrastructure and the government's own vaccine nationalism.
Right from the start, agreements and plans for the development of COVID-19 vaccines were going to privilege a profit-generating and market-based approach, writes Dale McKinley.
Vaccinations must reach all the peoples of the world, or COVID-19 will continue to spread, with the threat of more dangerous variants emerging, writes Barry Sheppard.
Rich nations, representing just 14% of the global population, have bought up 53% of the most promising COVID-19 vaccines so far, creating a global vaccine apartheid, writes Yanis Iqbal.
As the pandemic drags on, it's natural to long for a vaccine that will fix it. But, as Martin Wolterding and Coral Wynter explain, that may be harder to do than first thought.